Brainsway (BWAY) Non-Current Deffered Revenue (2018 - 2024)

Brainsway (BWAY) posted quarterly Non-Current Deffered Revenue of $8.5 million for Q4 2024, up 52.51% year-on-year from $5.6 million in Q1 2024, and down 6.3% on a QoQ basis from $9.0 million in Q3 2024.

Brainsway (BWAY) Non-Current Deffered Revenue (2018 - 2024) Analysis & Trends

Brainsway (BWAY) has reported Non-Current Deffered Revenue for 7 consecutive years, with $8.5 million the latest figure, recorded in Q4 2024.

  • Quarterly Non-Current Deffered Revenue rose 52.51% year-over-year to $8.5 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $8.5 million (up 52.51% YoY) and the FY2024 annual result came in at $8.5 million, up 52.51% from the prior year.
  • Non-Current Deffered Revenue declined to $8.5 million in Q4 2024 per BWAY's latest filing, from $9.0 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for BWAY reached as high as $9.0 million in Q3 2024 and fell as low as $2.0 million in Q2 2020.
  • A 5-year average of $4.5 million and a median of $4.6 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2020 — Non-Current Deffered Revenue fell 16.1% — and 2024, when it jumped 83.59%.
  • Year by year, Non-Current Deffered Revenue stood at $2.1 million in 2020, then surged by 66.54% to $3.4 million in 2021, then soared by 43.99% to $4.9 million in 2022, then rose by 12.8% to $5.6 million in 2023, then surged by 52.51% to $8.5 million in 2024.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $8.5 million, $9.0 million, and $4.4 million for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 512.79 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Brainsway 646.63 Mn 587.74 Mn 11.68 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 8.47 Mn
Sep 30, 2024 9.04 Mn
Jun 30, 2024 4.37 Mn
Mar 31, 2024 4.48 Mn
Dec 31, 2023 5.55 Mn
Sep 30, 2023 4.92 Mn
Jun 30, 2023 4.86 Mn
Mar 31, 2023 4.77 Mn
Dec 31, 2022 4.92 Mn
Dec 31, 2021 3.42 Mn
Dec 31, 2020 2.05 Mn
Sep 30, 2020 2.18 Mn
Jun 30, 2020 1.96 Mn
Mar 31, 2020 2.15 Mn
Dec 31, 2019 2.35 Mn
Sep 30, 2019 2.43 Mn
Jun 30, 2019 2.34 Mn
Mar 31, 2019 2.49 Mn
Dec 31, 2018 1.11 Mn
Sep 30, 2018 327,000.00